Orthopedic Regenerative Medicine Market Is Growing Rapidly With Eli Lily And Company Acquiring Prevail Therapeutics Including Clinical Program PR001, An Experimental Gene-Therapy For Neuronopathic Gaucher Disease

REGENERATIVE MEDICINE MARKET


 Orthopedic regenerative medicine is a rapidly expanding area of medical science. As medical science continues to discover new and effective ways to deliver treatments to patients, it is often changing the way we do surgery. For example, researchers have learned that by using stem cells in anti-inflammatory arthritis clinical trials, the pain experienced by some patients can be greatly reduced. Stem cells are also being used for the direct delivery of anti-inflammatory proteins in cartilage repair and tissue regeneration. These types of treatments hold great promise for treating a wide variety of ailments.

Rising prevalence of chronic diseases such as osteoarthritis and tendon, ligament, and cartilage injuries is expected to drive growth of the global orthopedic regenerative medicine market. According to the Centers for Disease Control and Prevention (CDC), osteoarthritis affects over 32.5 million U.S. adults. According to the global burden of disease study, around 10 to 15% of all adults aged 60 years and above suffer from some degree of osteoarthritis. Orthopedic regenerative medicines are typically helpful in the treatment of osteoarthritis and ligament injuries. Furthermore, regenerative medicines boost the body’s ability to use its repair systems to heal diseased or damaged cells due to arthritis. Hence, these factors are expected to drive growth of the global orthopedic regenerative medicine market. Furthermore, growing investments in regenerative medicine research and rising pipeline of regenerative medicine products are expected to propel the global orthopedic regenerative medicine market growth in the near future.

However, ethical concerns regarding the use of embryonic stem cells in R&D and high cost of gene therapies is expected to restrain growth of the global orthopedic regenerative medicine market. Besides, increasing demand for organ transplantations can present lucrative growth opportunities. Among regions, North America is expected to witness significant growth in the global orthopedic regenerative medicine market. This is owing to rising geriatric population suffering from osteoarthritis and the robust presence of major research organizations. Furthermore, Asia Pacific is expected to register a robust growth rate, owing to developing healthcare infrastructure in the region.

Key companies involved in the global orthopedic regenerative medicine market are AstraZeneca, Merck & Co., Inc., F Hoffmann-La Roche Ltd., Eli Lilly and Company, Pfizer Inc.,  Integra LifeSciences Corporation, and Baxter International.

For instance, in December 2021, Eli Lily and Company acquired Prevail Therapeutics including clinical program PR001, an experimental gene-therapy for neuronopathic Gaucher Disease.  

Comments

Popular posts from this blog

Astrum Has Expanded Its Presence In India Infrared Thermometer Market

Cfmoto Has Announced The Launch Of Its Electric Concept ATV To Expand Its Business In The Global All-Terrain Vehicle (ATV) Lighting Systems Market

The Global Meningococcal Vaccines Market Continues To Grow Owing To the Demand from Healthcare Care Sectors across the World to Prevent the Spread of the Diseases Especially In Children